Literature DB >> 6145086

Effect of Clostridium perfringens beta toxin on blood pressure of rats.

J Sakurai, Y Fujii, K Dezaki, K Endo.   

Abstract

Guanethidine treatment or adrenal medullectomy significantly inhibited the elevation in blood pressure induced by Clostridium perfringens beta toxin, and the combination of the two drastically reduced the pressure rise, to less than 19% of that in control rats. When rats were pretreated with tetrodotoxin or hexamethonium, the toxin-evoked rise was significantly inhibited. Elevation in blood pressure induced by the toxin in spinal rats tended to be less than that in control rats. When investigated by a microscopical technique, arteriolar constriction in the mesenteric vasculature was observed after the blood pressure elevation induced by the toxin reached a maximum. Blood flow in the skin decreased with an increase in blood pressure following intravenous injection of the toxin. It is concluded that beta toxin acts on the autonomic nervous system and produces arterial constriction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145086     DOI: 10.1111/j.1348-0421.1984.tb02944.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  11 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

2.  Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers.

Authors:  O Shatursky; R Bayles; M Rogers; B H Jost; J G Songer; R K Tweten
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China.

Authors:  J Liu; H Yang; Z Yin; X Jiang; H Zhong; D Qiu; F Zhu; R Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-17       Impact factor: 3.267

4.  Production, immunogenicity, stability, and safety of a vaccine against Clostridium perfringens beta toxins.

Authors:  Mohamed J Saadh; Issam J Sa'adeh; Moeen F Dababneh; Ammar M Almaaytah; Mohammad F Bayan
Journal:  Vet World       Date:  2020-08-07

5.  The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin.

Authors:  Masahiro Nagahama; Masahiro Shibutani; Soshi Seike; Mami Yonezaki; Teruhisa Takagishi; Masataka Oda; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

6.  Clostridium infection resulting in paralysis in a child.

Authors:  R Shane Tubbs; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2004-02-10       Impact factor: 1.475

7.  Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation.

Authors:  Masahiro Nagahama; Shinsuke Morimitsu; Atsushi Kihara; Masahiko Akita; Koujun Setsu; Jun Sakurai
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice.

Authors:  M Nagahama; A Kihara; H Kintoh; M Oda; J Sakurai
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 9.  Recent insights into Clostridium perfringens beta-toxin.

Authors:  Masahiro Nagahama; Sadayuki Ochi; Masataka Oda; Kazuaki Miyamoto; Masaya Takehara; Keiko Kobayashi
Journal:  Toxins (Basel)       Date:  2015-02-03       Impact factor: 4.546

10.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.